1-67367844-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001374259.2(IL12RB2):​c.1278G>C​(p.Gln426His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0439 in 1,595,256 control chromosomes in the GnomAD database, including 1,780 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q426Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.054 ( 271 hom., cov: 32)
Exomes 𝑓: 0.043 ( 1509 hom. )

Consequence

IL12RB2
NM_001374259.2 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0580

Publications

20 publications found
Variant links:
Genes affected
IL12RB2 (HGNC:5972): (interleukin 12 receptor subunit beta 2) The protein encoded by this gene is a type I transmembrane protein identified as a subunit of the interleukin 12 receptor complex. The coexpression of this and IL12RB1 proteins was shown to lead to the formation of high-affinity IL12 binding sites and reconstitution of IL12 dependent signaling. The expression of this gene is up-regulated by interferon gamma in Th1 cells, and plays a role in Th1 cell differentiation. The up-regulation of this gene is found to be associated with a number of infectious diseases, such as Crohn's disease and leprosy, which is thought to contribute to the inflammatory response and host defense. Several transcript variants encoding different isoforms and non-protein coding transcripts have been found for this gene. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0032021403).
BP6
Variant 1-67367844-G-C is Benign according to our data. Variant chr1-67367844-G-C is described in ClinVar as Benign. ClinVar VariationId is 1165356.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0783 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL12RB2NM_001374259.2 linkc.1278G>C p.Gln426His missense_variant Exon 11 of 17 ENST00000674203.2 NP_001361188.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL12RB2ENST00000674203.2 linkc.1278G>C p.Gln426His missense_variant Exon 11 of 17 NM_001374259.2 ENSP00000501329.1

Frequencies

GnomAD3 genomes
AF:
0.0539
AC:
8192
AN:
152018
Hom.:
269
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0805
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.0522
Gnomad ASJ
AF:
0.0879
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0124
Gnomad FIN
AF:
0.0291
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0477
Gnomad OTH
AF:
0.0631
GnomAD2 exomes
AF:
0.0389
AC:
9773
AN:
251432
AF XY:
0.0378
show subpopulations
Gnomad AFR exome
AF:
0.0787
Gnomad AMR exome
AF:
0.0340
Gnomad ASJ exome
AF:
0.0781
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0254
Gnomad NFE exome
AF:
0.0464
Gnomad OTH exome
AF:
0.0468
GnomAD4 exome
AF:
0.0429
AC:
61871
AN:
1443120
Hom.:
1509
Cov.:
27
AF XY:
0.0423
AC XY:
30424
AN XY:
719346
show subpopulations
African (AFR)
AF:
0.0782
AC:
2587
AN:
33076
American (AMR)
AF:
0.0370
AC:
1652
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.0832
AC:
2163
AN:
26000
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39608
South Asian (SAS)
AF:
0.0147
AC:
1259
AN:
85902
European-Finnish (FIN)
AF:
0.0277
AC:
1482
AN:
53408
Middle Eastern (MID)
AF:
0.0487
AC:
278
AN:
5712
European-Non Finnish (NFE)
AF:
0.0455
AC:
49813
AN:
1094944
Other (OTH)
AF:
0.0441
AC:
2637
AN:
59766
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
2757
5514
8271
11028
13785
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1836
3672
5508
7344
9180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0539
AC:
8207
AN:
152136
Hom.:
271
Cov.:
32
AF XY:
0.0520
AC XY:
3871
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.0806
AC:
3346
AN:
41500
American (AMR)
AF:
0.0521
AC:
796
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0879
AC:
305
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.0127
AC:
61
AN:
4820
European-Finnish (FIN)
AF:
0.0291
AC:
308
AN:
10584
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0477
AC:
3244
AN:
67976
Other (OTH)
AF:
0.0624
AC:
132
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
398
796
1194
1592
1990
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0428
Hom.:
147
Bravo
AF:
0.0565
TwinsUK
AF:
0.0512
AC:
190
ALSPAC
AF:
0.0524
AC:
202
ESP6500AA
AF:
0.0785
AC:
346
ESP6500EA
AF:
0.0485
AC:
417
ExAC
AF:
0.0386
AC:
4685
EpiCase
AF:
0.0511
EpiControl
AF:
0.0526

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

IL12RB2-related disorder Benign:1
Mar 02, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
8.8
DANN
Benign
0.95
DEOGEN2
Benign
0.064
T;.;.;.;T
Eigen
Benign
-0.56
Eigen_PC
Benign
-0.56
FATHMM_MKL
Benign
0.093
N
LIST_S2
Benign
0.0
.;T;T;T;T
MetaRNN
Benign
0.0032
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.5
M;M;.;M;M
PhyloP100
0.058
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.66
N;N;N;N;.
REVEL
Benign
0.051
Sift
Benign
0.14
T;T;T;T;.
Sift4G
Benign
0.069
T;T;T;T;.
Vest4
0.017
ClinPred
0.015
T
GERP RS
2.0
Varity_R
0.069
gMVP
0.33
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2307145; hg19: chr1-67833527; API